Playback speed
10 seconds
ESMO 2024 Insights: POD1UM-303/InterAACT 2 - Retifanlimab + C-P in Untreated Inoperable or Metastatic Anal Squamous Cell Carcinoma
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
Sheela Rao
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
Sheela Rao
5 views
September 27, 2024
Login to view comments.
Click here to Login